Increasing cardiac 18F-fluorodeoxyglucose (FDG) uptake on PET-CT as a biomarker for cardiotoxicity of chemo-radiotherapy in cancer: a myth or a reality?

dc.contributor.authorBasu, Sandip
dc.contributor.authorBorde, C.
dc.contributor.authorKand, P.
dc.date.accessioned2015-08-28T09:55:50Z
dc.date.available2015-08-28T09:55:50Z
dc.date.issued2014
dc.description.divisionRMCen
dc.format.extent3306 bytes
dc.format.mimetypetext/html
dc.identifier.sourceRadiotherapy and Oncology, 2014. Vol. 112 (3): pp. 451-452en
dc.identifier.urihttp://hdl.handle.net/123456789/11597
dc.language.isoenen
dc.subjectcardiac 18F-fluorodeoxyglucoseen
dc.subjectFDGen
dc.subjectPET-CTen
dc.subjectbiomarkeren
dc.subjectcardiotoxicityen
dc.subjectchemo-radiotherapyen
dc.subjectcanceren
dc.titleIncreasing cardiac 18F-fluorodeoxyglucose (FDG) uptake on PET-CT as a biomarker for cardiotoxicity of chemo-radiotherapy in cancer: a myth or a reality?en
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
1637.htm
Size:
3.23 KB
Format:
Hypertext Markup Language
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections